Cargando…
Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717257/ https://www.ncbi.nlm.nih.gov/pubmed/33537149 http://dx.doi.org/10.1093/jlb/lsaa083 |
| _version_ | 1783619300605558784 |
|---|---|
| author | Edmonds, Sterling MacGregor, Andrea Doll, Agnieszka Vural, Ipek Eren Graham, Janice Fierlbeck, Katherine Lexchin, Joel Doshi, Peter Herder, Matthew |
| author_facet | Edmonds, Sterling MacGregor, Andrea Doll, Agnieszka Vural, Ipek Eren Graham, Janice Fierlbeck, Katherine Lexchin, Joel Doshi, Peter Herder, Matthew |
| author_sort | Edmonds, Sterling |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7717257 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77172572020-12-09 Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19 Edmonds, Sterling MacGregor, Andrea Doll, Agnieszka Vural, Ipek Eren Graham, Janice Fierlbeck, Katherine Lexchin, Joel Doshi, Peter Herder, Matthew J Law Biosci Original Article Oxford University Press 2020-11-19 /pmc/articles/PMC7717257/ /pubmed/33537149 http://dx.doi.org/10.1093/jlb/lsaa083 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of Duke University School of Law, Harvard Law School, Oxford University Press, and Stanford Law School. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Original Article Edmonds, Sterling MacGregor, Andrea Doll, Agnieszka Vural, Ipek Eren Graham, Janice Fierlbeck, Katherine Lexchin, Joel Doshi, Peter Herder, Matthew Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19 |
| title | Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19 |
| title_full | Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19 |
| title_fullStr | Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19 |
| title_full_unstemmed | Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19 |
| title_short | Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19 |
| title_sort | transparency too little, too late? why and how health canada should make clinical data and regulatory decision-making open to scrutiny in the face of covid-19 |
| topic | Original Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717257/ https://www.ncbi.nlm.nih.gov/pubmed/33537149 http://dx.doi.org/10.1093/jlb/lsaa083 |
| work_keys_str_mv | AT edmondssterling transparencytoolittletoolatewhyandhowhealthcanadashouldmakeclinicaldataandregulatorydecisionmakingopentoscrutinyinthefaceofcovid19 AT macgregorandrea transparencytoolittletoolatewhyandhowhealthcanadashouldmakeclinicaldataandregulatorydecisionmakingopentoscrutinyinthefaceofcovid19 AT dollagnieszka transparencytoolittletoolatewhyandhowhealthcanadashouldmakeclinicaldataandregulatorydecisionmakingopentoscrutinyinthefaceofcovid19 AT vuralipekeren transparencytoolittletoolatewhyandhowhealthcanadashouldmakeclinicaldataandregulatorydecisionmakingopentoscrutinyinthefaceofcovid19 AT grahamjanice transparencytoolittletoolatewhyandhowhealthcanadashouldmakeclinicaldataandregulatorydecisionmakingopentoscrutinyinthefaceofcovid19 AT fierlbeckkatherine transparencytoolittletoolatewhyandhowhealthcanadashouldmakeclinicaldataandregulatorydecisionmakingopentoscrutinyinthefaceofcovid19 AT lexchinjoel transparencytoolittletoolatewhyandhowhealthcanadashouldmakeclinicaldataandregulatorydecisionmakingopentoscrutinyinthefaceofcovid19 AT doshipeter transparencytoolittletoolatewhyandhowhealthcanadashouldmakeclinicaldataandregulatorydecisionmakingopentoscrutinyinthefaceofcovid19 AT herdermatthew transparencytoolittletoolatewhyandhowhealthcanadashouldmakeclinicaldataandregulatorydecisionmakingopentoscrutinyinthefaceofcovid19 |